NURS6521 / NURS /2021 Quiz - Week 6/ MIDTERM GRADED 28/30

Review Test Submission: Week 6 -Quiz NURS6521 / NURS 6521 2020/2021 Quiz - Week 6/ MIDTERM GRADED 28/30 • Question 1 1 out of 1 points A patient in need of myocardial infarction prophylaxis has been prescribed sulfinpyrazone for gout. Which of the following will the nurse monitor the patient most closely for? Response Feedback: Since sulfinpyrazone inhibits antiplatelet action, it is important for the nurse to monitor the patient for signs of bleeding. It is also important to avoid administration of sulfinpyrazone with other drugs such as salicylates and anticoagulants (warfarin) that affect platelet aggregation. The drug does not pose a risk of hypothermia, hypotension, or renal dysfunction. • Question 2 1 out of 1 points A patient is taking gabapentin (Neurontin) for spasticity associated with multiple sclerosis. Which of the following should be the priority for monitoring? Response Feedback: Gabapentin is not metabolized and is excreted unchanged in the urine. Therefore, it is important to monitor renal function. Hepatic, cardiac, and respiratory functions are not compromised with this drug. • Question 3 1 out of 1 points A nurse is developing a care plan for a patient who has multiple sclerosis. An expected outcome for the patient who is receiving glatiramer would be a decrease in Response Feedback: Glatiramer should reduce the frequency of multiple sclerosis–related attacks and therefore decrease fatigue. Fatigue, weakness, spasticity, balance problems, bladder and bowel problems, numbness, vision loss, tremor, and vertigo are the most common symptoms of multiple sclerosis. Chest pain, breathing difficulties, and heart palpitations are all identified side effects of glatiramer and are not common manifestations of MS. • Question 4 0 out of 1 points A patient with type 1 diabetes has been admitted to the hospital for orthopedic surgery and the care team anticipates some disruptions to the patient's blood glucose levels in the days following surgery. Which of the following insulin regimens is most likely to achieve adequate glycemic control? Response Feedback: Subcutaneous insulin therapy for type 1 diabetes frequently consists of daily injections of mixtures of short-acting regular insulin with intermediate-acting insulins; multiple doses of regular insulin before each meal in association with one or two daily doses of long-acting insulin may also be used. Frequent, fixed doses of rapid-acting or intermediate-acting insulin may result in unsafe blood sugar levels. • Question 5 1 out of 1 points A patient receives 25 units of NPH insulin at 7.AM. At what time of day should the nurse advise the patient to be most alert for a potential hypoglycemic reaction? Response Feedback: After an early morning dose of NPH insulin, the patient should be alert for a possible hypoglycemic reaction during mid- to late-afternoon. The lengthy peak action time produces additional risks for hypoglycemic reactions. • Question 6 1 out of 1 points A 49-year-old woman has been diagnosed with myalgia. The physician has recommended aspirin. The patient is concerned that the aspirin will upset her stomach. The nurse will encourage the patient to Response Feedback: Taking aspirin with milk or food minimizes the stomach upset because it buffers the stomach wall from direct contact with the medication, decreasing gastric distress. Chewable tablets can be chewed before swallowing or crushed and then advised to be taken with food or mixed in a drink. Swallowed whole, extended-release tablets are enteric coated to delay release of the aspirin, which again buffers the stomach wall from the medication, decreasing gastric distress. Nonchewable tablets should be swallowed whole and should never be advised to be crushed or chewed. • Question 7 1 out of 1 points A 40-year-old woman with a diagnosis of fibromyalgia has been prescribed cyclobenzaprine (Flexeril) as an adjunct to her existing drug regimen. What nursing diagnosis should the nurse prioritize when updating the nursing care plan for this patient? Response Feedback: The CNS depression that is associated with the use of cyclobenzaprine constitutes a risk for injury. The anticholinergic effects of the drug constitute a risk for constipation, not diarrhea. Nutrition and swallowing are not typically affected by the use of cyclobenzaprine.